نتایج جستجو برای: echinocandins

تعداد نتایج: 803  

2017
Huang-Tz Ou Tsung-Ying Lee Yee-Chun Chen Claudie Charbonneau

BACKGROUND Cost-effectiveness studies of echinocandins for the treatment of invasive candidiasis, including candidemia, are rare in Asia. No study has determined whether echinocandins are cost-effective for both Candida albicans and non-albicans Candida species. There have been no economic evaluations that compare non-echinocandins with the three available echinocandins. This study was aimed to...

Journal: :Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2014
Cătălina Daniela Stan Cristina Tuchiluş C I Stan

Over the past 10-15 years, the number of clinically available antifungal agents has increased substantially, due to rise in the number of invasive fungal infections, which are a real problem for specialists. Echinocandins are the new class of antifungal agents available for clinical use. This class comprises over 20 natural echinocandins and several semisynthetic ones. Natural echinocandins are...

2010
Carol A Munro

The echinocandins are the newest class of antifungal agents in the clinical armory. These secondary metabolites are non-competitive inhibitors of the synthesis of beta-(1,3)-glucan, a major structural component of the fungal cell wall. Recent work has shown that spontaneous mutations can arise in two hot spot regions of Fks1 the target protein of echinocandins that reduce the enzyme's sensitivi...

Journal: :American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2006
Michele I Morris Mark Villmann

PURPOSE The chemistry, pharmacology, spectrum of activity, resistance, pharmacokinetics, pharmacodynamics, clinical efficacy, adverse effiects, drug interactions, dosage and administration, cost, and place in therapy of echinocandins are reviewed. SUMMARY Three echinocandins are currently available: caspofungin, micafungin, and anidulafungin. The principal mechanism of action of the echinocan...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015
Thomas J Walsh Nkechi Azie David R Andes

Echinocandins are N-acyl-substituted cyclic hexapeptides with potent in vitro and in vivo activity against Candida species that are used for primary treatment and prevention of candidemia and invasive candidiasis. Recent progress in the translational research of echinocandins has led to new approaches for treatment of central venous catheter Candida biofilms. Other studies have laid the experim...

Journal: :Antimicrobial agents and chemotherapy 2014
Janet F Staab Dionysios Neofytos Peter Rhee Cristina Jiménez-Ortigosa Sean X Zhang David S Perlin Kieren A Marr

Candida kefyr is an increasingly reported pathogen in patients with hematologic malignancies. We studied a series of bloodstream isolates that exhibited reduced echinocandin susceptibilities (RES). Clinical and surveillance isolates were tested for susceptibilities to all three echinocandins, and those isolates displaying RES to one or more echinocandins were selected for molecular and biochemi...

2014
Francisco Javier González de Molina Maria de Los Ángeles Martínez-Alberici Ricard Ferrer

Echinocandins are indicated as first-line treatment for invasive candidiasis in moderate to severe illness. As sepsis is the main cause of acute kidney injury, the combination of echinocandin treatment and continuous renal replacement therapy (CRRT) is common. Optimizing antibiotic dosage in critically ill patients receiving CRRT is challenging. The pharmacokinetics of echinocandins have been s...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006
Mini Kamboj David Weinstock Kent A Sepkowitz

Echinocandins are a novel class of antifungal drugs that target beta (1, 3)-D-glucan synthesis. Animal studies have shown that these agents have activity against Pneumocystis jiroveci infection; however, clinical data are lacking. We reviewed all cases of proven P. jiroveci pneumonia (PCP) in non-human immunodeficiency virus-infected patients at our hospital over a 5 year period (2001-2005). Tw...

Journal: :Proceedings 2002
Joseph Rybowicz Cheryle Gurk-Turner

Caspofungin acetate (Cancidas, MK-0991, L-743,872) is a parenteral antifungal agent indicated in the treatment of invasive aspergillosis in patients who are intolerant of or whose infection is refractory to other antifungal therapies. It is the first member of a novel class of antifungals, the echinocandins, to be made available in the USA. As a class, the echinocandins possess a mechanism of a...

Journal: :Antimicrobial agents and chemotherapy 2011
Scott S Walker Yiming Xu Ilias Triantafyllou Michelle F Waldman Cara Mendrick Nathaniel Brown Paul Mann Andrew Chau Reena Patel Nicholas Bauman Christine Norris Barry Antonacci Maya Gurnani Anthony Cacciapuoti Paul M McNicholas Samuel Wainhaus R Jason Herr Rongze Kuang Robert G Aslanian Pauline C Ting Todd A Black

The echinocandins are a class of semisynthetic natural products that target β-1,3-glucan synthase (GS). Their proven clinical efficacy combined with minimal safety issues has made the echinocandins an important asset in the management of fungal infection in a variety of patient populations. However, the echinocandins are delivered only parenterally. A screen for antifungal bioactivities combine...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید